You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Metabolic conditions

Vitamin D: supplement use in specific population groups

  • Public health guideline
  • Reference number: PH56
  • Published:  26 November 2014
  • Last updated:  30 August 2017
  • Guidance
  • Tools and resources
  • Evidence
  • History
Download guidance (PDF)
  • Overview
  • What is this guideline about?
  • Recommendations
  • Who should take action?
  • Context
  • Considerations
  • Recommendations for research
  • Related NICE guidance
  • Glossary
  • References
  • Summary of the methods used to develop this guideline
  • The evidence
  • Gaps in the evidence
  • Membership of the Public Health Advisory Committee and the NICE project team
  • About this guideline
  • Update information

References

Jessiman T, Cameron A, Wiggins M et al. (2013) A qualitative study of uptake of free vitamins in England. Archives of Disease in Childhood 98: 587–91

McGee E, Shaw N (2013) Vitamin D supplementation: Putting recommendations into practice. Journal of Health Visiting 1 (3): 138–43

Moonan M, Hanratty B, Whitehead M (2012) Which is more effective, a universal or targeted approach, to implementing the National Healthy Start Programme? A mixed methods study. Journal of Epidemiology and Community Health 66: A44–5

Pearce SHS, Cheetham TD (2010) Diagnosis and management of vitamin D deficiency. BMJ 340: b5664

Sattar N, Welsh P, Panarelli M et al. (2012) Increasing requests for vitamin D measurement: costly, confusing, and without credibility The Lancet 379 (9811): 95–6

Zipitis CS, Markides GA, Swann IL (2006) Vitamin D deficiency: prevention or treatment? Archives of Disease in Childhood 91: 1011–4


Next page Summary of the methods used to develop this guideline Previous page Glossary
Back to top